Next 10 |
SARASOTA, Fla. , May 15, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today anno...
SARASOTA, Fla. , April 2, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today the appointment of Christopher A. Myer as Vice President Business Development ...
SARASOTA, Fla. , March 11, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced that Yve Lyppens has been appointed Director Business Development Asia Pacific....
SARASOTA, Fla. , Feb. 13, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced the appointment of Inger Britt Carlsson , PhD, as the Company's Vice President ...
SARASOTA, Fla. , Feb. 5, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell ® product, today announced receipt of Institutional Review Board (IRB) approval to commence its planned cl...
SARASOTA, Fla. , Jan. 21, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today that the Company plans to attend the 45 th Edition of Arab Health Exhibition and Con...
SARASOTA, Fla. , Jan. 16, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, and Medesole, a leading supplier of healthcare products in India and the Middle East , today annou...
The following slide deck was published by INVO Bioscience, Inc. in conjunction with their 2019 Q3 earnings Read more ...
INVO Bioscience, Inc. (IVOB) Q3 2019 Results Earnings Conference Call November 21, 2019, 11:00 AM ET Company Participants Robert Blum - Lytham Partners Steven Shum - CEO Michael Campbell - Company’s COO and VP of Business Development Conference Call Participants Pre...
SARASOTA, Fla. , Nov. 14, 2019 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today a...
News, Short Squeeze, Breakout and More Instantly...
INVO BioScience, Inc. Company Name:
IVOB Stock Symbol:
OTCMKTS Market:
INVO BioScience, Inc. Website:
SARASOTA, Fla. , May 15, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, today anno...
SARASOTA, Fla. , April 2, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: INVO) , a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, announced today the appointment of Christopher A. Myer as Vice President Business Development ...
SARASOTA, Fla. , March 11, 2020 /PRNewswire/ -- INVO Bioscience, Inc. (OTCQB: IVOB), a medical device company focused on treating infertility with its FDA-cleared INVOcell® product, today announced that Yve Lyppens has been appointed Director Business Development Asia Pacific....